Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CNOOC
00883
5
SINOPEC CORP
00386
| (Q1)Dec 31, 2025 | (FY)Sep 30, 2025 | (Q4)Sep 30, 2025 | (Q3)Jun 30, 2025 | (Q2)Mar 31, 2025 | (Q1)Dec 31, 2024 | (FY)Sep 30, 2024 | (Q4)Sep 30, 2024 | (FY)Sep 30, 2023 | (FY)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (Indirect Method) | ||||||||||
| Cash from operating activities | 77.29%13.31M | 40.33%31.44M | 3.32%8.98M | 8.08M | 6.87M | 7.51M | -29.52%22.4M | 8.69M | -7.14%31.79M | -3.66%34.23M |
| Net profit before non-cash adjustment | 398.67%9.03M | 39.39%26.57M | 416.38%9.68M | --7.91M | --7.18M | --1.81M | -18.31%19.06M | --1.87M | -51.18%23.34M | 88.95%47.8M |
| Total adjustment of non-cash items | 573.15%2.24M | -54.76%5.19M | -69.69%1.65M | --2.22M | --1.8M | ---473K | 54.68%11.48M | --5.44M | 171.27%7.42M | -63.86%2.74M |
| -Depreciation and amortization | 13.78%2.27M | 2.19%8.25M | 9.51%2.15M | --2.08M | --2.02M | --2M | 3.10%8.07M | --1.97M | 12.31%7.83M | 0.42%6.97M |
| -Reversal of impairment losses recognized in profit and loss | ---1.11M | 632.01%1.78M | 841.36%1.78M | ---- | ---- | --0 | 585.63%242.82K | --188.82K | -104.87%-50K | 346.09%1.03M |
| -Disposal profit | 14.64%-379K | -1,671.95%-2.16M | -1,632.61%-2.11M | ---18K | --414K | ---444K | 71.36%-122K | ---122K | 82.35%-426K | ---2.41M |
| -Net exchange gains and losses | 197.80%1.73M | -150.69%-1.34M | -92.73%250.31K | --535K | ---349K | ---1.77M | 352.86%2.63M | --3.44M | 72.63%-1.04M | -627.92%-3.81M |
| -Other non-cash items | -8.33%-273K | -303.95%-1.33M | -1,035.56%-418.17K | ---380K | ---284K | ---252K | -41.17%654.18K | ---36.83K | 15.83%1.11M | 4.12%960K |
| Changes in working capital | -66.86%2.05M | 95.99%-326.28K | -270.09%-2.35M | ---2.05M | ---2.11M | --6.17M | -889.54%-8.14M | --1.38M | 106.32%1.03M | -712.05%-16.31M |
| -Change in receivables | -20.87%2.15M | -30.94%-6.52M | -66.68%618.91K | ---5.94M | ---3.92M | --2.72M | -176.43%-4.98M | --1.86M | 222.94%6.51M | -803.32%-5.3M |
| -Change in inventory | -90.59%-972K | -630.29%-1.27M | 151.34%59.74K | ---930K | --107K | ---510K | -115.92%-174.35K | ---116.35K | 264.41%1.1M | 69.14%-666K |
| -Change in payables | -78.12%867K | 349.66%7.46M | -734.58%-3.02M | --4.82M | --1.7M | --3.96M | 54.53%-2.99M | ---362.33K | 36.43%-6.58M | -354.19%-10.34M |
| Dividends paid (cash flow from operating activities) | ||||||||||
| Dividends received (cash flow from operating activities) | ||||||||||
| Interest paid (cash flow from operating activities) | 56.52%-140K | 42.51%-782K | 51.93%-176K | -123K | -161K | -322K | -36.02%-1.36M | -366.15K | -15.87%-1M | 6.30%-863K |
| Interest received (cash flow from operating activities) | -15.55%391K | 178.28%2.13M | 56.10%556.83K | 582K | 529K | 463K | 658.12%765.7K | 356.7K | 380.95%101K | -27.59%21K |
| Tax refund paid | -16.00%-1.77M | -20.55%-8.02M | -101.54%-2.75M | -2.22M | -1.52M | -1.53M | 18.37%-6.65M | -1.36M | 14.25%-8.15M | -182.86%-9.5M |
| Other operating cash inflow (outflow) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating cash flow | 92.57%11.79M | 63.42%24.77M | -9.65%6.61M | --6.32M | --5.72M | --6.12M | -33.35%15.16M | --7.32M | -4.80%22.74M | -23.64%23.89M |
| Investing cash flow | ||||||||||
| Net PPE purchase and sale | -285.34%-8.91M | -584.34%-19.12M | -339.60%-10.86M | ---4.23M | ---1.72M | ---2.31M | 74.17%-2.79M | ---2.47M | -316.56%-10.82M | 80.12%-2.6M |
| Net investment product transactions | 107.36%5.26M | ---52.12M | ---- | ---- | ---- | ---71.5M | --0 | ---- | ---- | ---- |
| Net changes in other investments | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --1.7M | ---- |
| Investing cash flow | 95.05%-3.65M | -2,449.76%-71.25M | -2,449.69%-62.98M | ---4.23M | --69.78M | ---73.81M | 69.35%-2.79M | ---2.47M | -251.10%-9.12M | 80.12%-2.6M |
| Financing cash flow | ||||||||||
| Net issuance payments of debt | 67.98%-162K | -1,500.94%-22.92M | 55.91%-166.09K | ---160K | ---22.09M | ---506K | 51.19%-1.43M | ---376.73K | 35.78%-2.93M | -309.96%-4.57M |
| Net common stock issuance | --0 | 8,466,282.77%84.49M | 25,100.00%500 | --0 | --0 | --84.49M | --998 | ---2 | --0 | -50.00%300K |
| Increase or decrease of lease financing | 99.63%-74K | 40.12%-1.21M | 86.42%-68.95K | ---176K | --19.05M | ---20.02M | -67.40%-2.03M | ---507.56K | -1.68%-1.21M | -97.35%-1.19M |
| Issuance fees | --0 | ---2.41M | --144 | --0 | --0 | ---2.41M | --0 | --0 | ---- | ---- |
| Cash dividends paid | ---- | ---- | ---- | ---- | ---- | ---- | ---2M | --0 | ---- | ---1.02M |
| Net other fund-raising expenses | ---- | -11.16%-24.22K | 72.48%-216 | --0 | ---- | ---- | -55.61%-21.79K | ---785 | -7.69%-14K | 40.91%-13K |
| Financing cash flow | -100.38%-236K | 1,157.37%57.92M | 73.49%-234.61K | ---336K | ---3.06M | --61.56M | -31.78%-5.48M | ---885.07K | 35.95%-4.16M | -469.80%-6.49M |
| Net cash flow | ||||||||||
| Beginning cash position | 14.01%98.3M | 6.33%86.22M | 82.66%155.18M | --153.78M | --81.05M | --86.22M | 15.43%81.09M | --84.96M | 34.93%70.25M | 50.66%52.06M |
| Current changes in cash | 228.81%7.9M | 66.25%11.45M | -1,528.58%-56.61M | --1.76M | --72.43M | ---6.13M | -27.26%6.88M | --3.96M | -36.05%9.47M | -13.33%14.8M |
| Effect of exchange rate changes | -251.19%-1.46M | 136.32%637.39K | 89.94%-271.61K | ---355K | --299K | --965K | -227.45%-1.75M | ---2.7M | -59.31%1.38M | 690.65%3.38M |
| End cash Position | 29.23%104.74M | 14.01%98.3M | 14.01%98.3M | --155.18M | --153.78M | --81.05M | 6.33%86.22M | --86.22M | 15.43%81.09M | 34.93%70.25M |
| Free cash flow | -24.46%2.88M | -56.39%5.34M | -193.40%-4.41M | --2.05M | --3.9M | --3.81M | 5.69%12.24M | --4.73M | -21.73%11.58M | -18.76%14.8M |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.